UPDATE 1-Merck, Bristol-Myers agree to settle Keytruda patent suit
January 20, 2017 at 17:20 PM EST
Jan 20 (Reuters) - Merck & Co said it agreed to enter into a settlement and license agreement with Bristol-Myers Squibb Co and Ono Pharmaceutical Co Ltd to resolve all global patent-infringement litigation related to its cancer drug, Keytruda.
